We are monitoring the impact of COVID-19 on APAC Zika Virus Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5815
Share on
Share on

Asia Pacific Zika Virus Vaccines Market Research Report - Segmented By Type, End-user, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 5815
Pages: 145

APAC Zika Virus Vaccines Market Size (2021 to 2026)

The Zika Virus Vaccines Market size in the Asia Pacific was worth USD 2.78 billion in 2021 and estimated to be growing at a CAGR of 7.56% to reach USD 4.00 billion by 2026.

Zika virus is a mosquito-borne fever caused by Aedes mosquitoes when they are active in the day-time. It is similar to yellow fever, West Nile virus, and dengue. Zika vaccines are developed to prevent and control diseases caused by zika virus. This disease has no symptoms or sometimes very mild symptoms like a minimal form of dengue fever, skin rash, and joint pains. It is transmitted sexually from the infected person or the infected pregnant woman to the baby.

There are different types of vaccines developing to protect against viruses, such as mRNA vaccines, DNA-based vaccines, genetically engineered vaccines, and inactivated vaccines. With the rise in zika virus incidences, many pharmaceutical and biotechnology companies are investing in this market. In very rare cases, the zika virus is also transmitted through blood transfusion. In 2016, the World Health Organization (WHO) declared that the major causes of the zika virus were asymptomatic.

Factors like rising incidences of zika virus, growing people awareness about zika infection, high investment by private companies in the R&D of zika virus, serious attention due to high risk to the pregnant women, favorable government reimbursements, potential demand for zika vaccine, and technology advancements in the healthcare industry are driving the Asia-Pacific Zika Virus Vaccines market.

However, the lack of awareness among the people and WHO announcing it as an epidemic projected to have less potential in the coming days is hindering the market growth.

This research report on the APAC Zika Virus Vaccines Market has been segmented & sub-segmented into the following categories:

By Type:

  • Therapeutic Vaccines
  • Preventive Vaccines

By End-User:

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, Asia-Pacific is anticipated to have the fastest-growing rate with the highest CAGR during the forecast period. This is due to the presence of emerging economies like India and China, which attracted strong pharmaceutical companies.

Notable companies operating in the APAC Zika virus vaccines market profiled in this report are Takeda Pharmaceutical Co. Ltd., NewLink Genetics Co., Immunovaccine Inc., GeneOne Life Science Inc., GlaxoSmithKline plc., Inovio Pharmaceuticals, Inc., Bharat Biotech International Ltd., Hawaii Biotech Inc., and Sanofi S.A.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Therapeutic Vaccines         

                                5.1.3 Preventive Vaccines           

                                5.1.4 Y-o-Y Growth Analysis, By Type     

                                5.1.5 Market Attractiveness Analysis, By Type   

                                5.1.6 Market Share Analysis, By Type     

                5.2 End-user                      

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Clinics        

                                5.2.4 Research institutes              

                                5.2.5 Others      

                                5.2.6 Y-o-Y Growth Analysis, By End-user             

                                5.2.7 Market Attractiveness Analysis, By End-user           

                                5.2.8 Market Share Analysis, By End-user             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Type

                                       By End-user

                                6.1.4  Market Attractiveness Analysis     

                                       By Geographical Area

                                       By Type

                                       By End-user

                                6.1.5  Market Share Analysis      

                                       By Geographical Area

                                       By Type

                                       By End-user

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Takeda Pharmaceutical Co. Ltd.,                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 NewLink Genetics Co.,                          

                8.3 Immunovaccine Inc.,                              

                8.4 GeneOne Life Science Inc.,                  

                8.5 GlaxoSmithKline plc.,                             

                8.6 ., Inovio Pharmaceuticals, Inc.,                           

                8.7 Bharat Biotech International Ltd.,                     

                8.8 Hawaii Biotech Inc.,                 

                8.9 Sanofi S.A.                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms Hospitals, Clinics, Research with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Zika Virus Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Therapeutic Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific Preventive Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Zika Virus Vaccines Market, By End-user, From 2021 to 2026 (USD Billion)
  5. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  6. Asia Pacific Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Research Institutes Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  9. Japan Zika Virus Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  10. Japan Zika Virus Vaccines Market, By End-user, From 2021 to 2026 (USD Billion)
  11. China Zika Virus Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  12. China Zika Virus Vaccines Market, By End-user, From 2021 to 2026 (USD Billion)
  13. India Zika Virus Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  14. India Zika Virus Vaccines Market, By End-user, From 2021 to 2026 (USD Billion)
  15. Australia Zika Virus Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  16. Australia Zika Virus Vaccines Market, By End-user, From 2021 to 2026 (USD Billion)
  17. South Korea Zika Virus Vaccines Market, By Type, From 2021 to 2026 (USD Billion)
  18. South Korea Zika Virus Vaccines Market, By End-user, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample